Virtual and Physical Prototyping is a premier scholarly journal published by Taylor & Francis Ltd, which has established itself as a leading platform for innovative research in the fields of Computer Graphics, Computer-Aided Design, Industrial and Manufacturing Engineering, Modeling and Simulation, and Signal Processing. Since its inception in 2006, the journal has gained significant recognition, currently ranked in the Q1 quartile in multiple categories, reflecting its high impact and rigorous standards of scholarship. Now an Open Access journal as of 2023, it provides a unique opportunity for researchers, professionals, and students to share their work widely and engage with a global audience. With its strategic emphasis on the convergence of virtual and physical prototyping technologies, this journal contributes vital knowledge and insights that drive innovation and development in manufacturing processes and design methodologies. Located in the United Kingdom, its comprehensive approach to both theoretical and practical aspects of prototyping ensures that it remains an essential resource for advancing the respective fields it represents.

Advanced Biology, published by WILEY-V C H VERLAG GMBH, serves as a premier platform where innovative research and scientific breakthroughs in the fields of biochemistry, genetics, and molecular biology converge. Established in 2021, this journal has rapidly ascended to prominence, securing Q1 rankings in its primary categories, including general biochemistry and biomedical engineering, and a solid Q2 ranking in biomaterials. With an ISSN of 2701-0198 and an emphasis on open access, Advanced Biology ensures that rigorous peer-reviewed research is accessible to a global audience, enhancing visibility and fostering collaboration among researchers, professionals, and students alike. By 2024, it aims to continually elevate scientific understanding and innovation, catering to the growing interdisciplinary nature of these critical fields. With Scopus rankings placing it amongst the top quartiles in its disciplines, Advanced Biology is poised to make significant contributions to the future of life sciences.

Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.

ACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.

Tissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.

Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.

Nanocomposites, published by Taylor & Francis Ltd, is a leading open-access journal dedicated to the interdisciplinary field of nanomaterials and their applications in composites. With its ISSN 2055-0324 and E-ISSN 2055-0332, the journal has established itself as a premier platform for disseminating high-quality research since its inception in 2015. It is notable for its impressive Q1 rankings across various categories, including Ceramics and Composites, Materials Chemistry, Mechanical Engineering, and Mechanics of Materials, reflecting its significant impact on the scientific community. The journal is recognized for its rigorous peer-review process and rapid publication times, making it an essential resource for researchers and professionals seeking to advance knowledge in the synthesis, characterization, and application of nanocomposite materials. With an open access policy implemented in 2017, Nanocomposites ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across disciplines. Emphasizing the critical role that nanocomposites play in advancing technology, this journal invites contributions that push the boundaries of current understanding and application.

The International Journal of Polymeric Materials and Polymeric Biomaterials, published by Taylor & Francis AS, stands at the forefront of materials science, showcasing groundbreaking research in the fields of Analytical Chemistry, Chemical Engineering, and Polymeric Materials. With an ISSN of 0091-4037 and an E-ISSN of 1563-535X, this esteemed journal, established in 1971, serves as a vital platform for academics and professionals seeking to disseminate innovative findings and elevate the understanding of polymeric materials. Featuring a commendable impact factor and ranking in the top quartiles of its categories—Q2 in Analytical Chemistry, Chemical Engineering, and Polymers and Plastics—the journal is a pivotal resource for researchers aiming to leverage polymer science in various applications. Although it does not offer open access, its rigorous peer-review process ensures that only high-quality research is published, making it an essential reference for anyone involved in polymer research and development.

Journal of the Mechanical Behavior of Biomedical Materials is a leading academic publication dedicated to the intersection of mechanical engineering and biomedical innovation. Published by ELSEVIER in the Netherlands, this journal, which holds a solid presence within Q2 in Biomaterials and Biomedical Engineering, and Q1 in Mechanics of Materials as of 2023, features high-impact research with a measurable Scopus ranking that places it in the top tier of its fields. With an impressive percentile performance—82nd in Mechanics of Materials and 73rd in Biomedical Engineering—this journal serves as a vital resource for researchers, students, and professionals seeking to enrich their understanding of the mechanical behaviors of biomaterials and their applications. Spanning converged years from 2008 to 2024, it provides access to a wealth of pioneering research that advances the knowledge essential for the development of innovative biomedical applications. Engage with cutting-edge studies and broaden your expertise in the rapidly evolving realms of biomaterials and biomedical engineering through this authoritative publication.

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.